Relative concentrations of endotoxin-binding proteins in body fluids during infection
- PMID: 7520106
- DOI: 10.1016/s0140-6736(94)91767-1
Relative concentrations of endotoxin-binding proteins in body fluids during infection
Abstract
Endotoxin initiates the systemic inflammatory response, haemodynamic changes, and multi-organ failure that may occur as a consequence of systemic gram-negative bacterial infection. The serum protein lipopolysaccharide-binding protein (LBP) binds to the lipid A component of bacterial endotoxin and facilitates its delivery to the CD14 antigen on the macrophage, where inflammatory cytokines are released and a cascade of host mediators is initiated. The neutrophil granular protein bactericidal/permeability-increasing protein (BPI) competes with LBP for endotoxin binding and functions as a molecular antagonist of LBP-endotoxin interactions. We have measured concentrations of both proteins in body fluids from 49 consecutive patients. In 16 of 17 samples of fluid from closed-space infections, BPI was present in greater concentration than LBP (median BPI/LBP ratio 7.6 [95% CI 2.32-22.1]). The ratio of BPI and LBP was not significantly different from 1.0 in abdominal fluid from 10 patients with peritonitis (ratio 0.235 [0.18-0.47]), whereas the BPI/LBP ratio was low in 22 non-infected body fluids (0.01 [0.001-0.04]) and concentrations of both proteins approached those in normal human plasma. BPI concentrations were directly correlated with the quantity of neutrophils within clinical samples (rs = 0.81, p < 0.0001). Thus, within abscess cavities BPI is available in sufficient quantities for effective competition with LBP for endotoxin. BPI may attenuate the local inflammatory response and the systemic toxicity of endotoxin release during gram-negative infections.
Similar articles
-
Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis.Arch Surg. 1994 Feb;129(2):220-6. doi: 10.1001/archsurg.1994.01420260116016. Arch Surg. 1994. PMID: 7508221
-
Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP): structure, function and regulation in host defence against Gram-negative bacteria.Biochem Soc Trans. 2003 Aug;31(Pt 4):785-90. doi: 10.1042/bst0310785. Biochem Soc Trans. 2003. PMID: 12887306 Review.
-
Plasma lipopolysaccharide binding protein and bactericidal/permeability increasing factor in CRF and HD patients.J Am Soc Nephrol. 1996 Mar;7(3):479-87. doi: 10.1681/ASN.V73479. J Am Soc Nephrol. 1996. PMID: 8704115
-
Lipopolysaccharide-binding protein and bactericidal/permeability-increasing factor during hemodialysis: clinical determinants and role of different membranes.J Am Soc Nephrol. 1997 Mar;8(3):463-70. doi: 10.1681/ASN.V83463. J Am Soc Nephrol. 1997. PMID: 9071715
-
The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies.J Leukoc Biol. 2001 Apr;69(4):505-12. J Leukoc Biol. 2001. PMID: 11310835 Review.
Cited by
-
Endotoxin-directed innate immunity in tracheal aspirates of mechanically ventilated human neonates.Pediatr Res. 2009 Aug;66(2):191-6. doi: 10.1203/PDR.0b013e3181aa33d7. Pediatr Res. 2009. PMID: 19390484 Free PMC article.
-
The anti-inflammatory effect of the synthetic antimicrobial peptide 19-2.5 in a murine sepsis model: a prospective randomized study.Crit Care. 2013 Jan 9;17(1):R3. doi: 10.1186/cc11920. Crit Care. 2013. PMID: 23302299 Free PMC article.
-
Activity of lipopolysaccharide-binding protein-bactericidal/permeability-increasing protein fusion peptide in an experimental model of Pseudomonas sepsis.Antimicrob Agents Chemother. 1995 Dec;39(12):2813-5. doi: 10.1128/AAC.39.12.2813. Antimicrob Agents Chemother. 1995. PMID: 8593028 Free PMC article.
-
Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate.J Clin Invest. 1995 Apr;95(4):1916-24. doi: 10.1172/JCI117873. J Clin Invest. 1995. PMID: 7706499 Free PMC article.
-
The level of lipopolysaccharide-binding protein is significantly increased in plasma in patients with the systemic inflammatory response syndrome.Clin Diagn Lab Immunol. 1997 Mar;4(2):113-6. doi: 10.1128/cdli.4.2.113-116.1997. Clin Diagn Lab Immunol. 1997. PMID: 9067641 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous